Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Cardinal Health (CAH) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareCAH

Latest price · Nov 20, 2026 $275.21 +1.1% on the day · +33.6% over 12 months 52-week range $181.68 – $283.85
Get CAH alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling8last 12 months
Reported sales$61.6M0 of 35 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification) and isn't treated as a signal here.

Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Feb 11, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Jason M. Hollar, CEO sold 29,915 shares at $235.51 ($7.0M).

Trade date
Aug 18, 2026
Disclosed to the SEC
Aug 20, 2026
Type
Sale (code S)

Read the original SEC filing ↗All CAH insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

CAH insider transactions (Form 4)

Open-market purchases and sales. 53 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Aug 20SEC Jason M. HollarCEO Sell 29,915263,810 held (−10%) $235.51 $7.0M +16.9% —
Aug 20SEC Jason M. HollarCEO Sell 21,407293,725 held (−7%) $234.56 $5.0M +17.3% —
Aug 20SEC Jason M. HollarCEO Sell 16,187196,847 held (−8%) $237.23 $3.8M +16.0% —
Aug 20SEC Jason M. HollarCEO Sell 16,208247,602 held (−6%) $236.54 $3.8M +16.4% —
Aug 20SEC Aaron E. AltCFO Sell 13,68533,467 held (−29%) $236.58 $3.2M +16.3% —
Aug 20SEC Aaron E. AltCFO Sell 12,97220,495 held (−39%) $237.26 $3.1M +16.0% —
Aug 20SEC Stephen M. MasonCEO Sell 12,82918,061 held (−42%) $237.26 $3.0M +16.0% —
Aug 20SEC Jason M. HollarCEO Sell 12,470235,132 held (−5%) $237.25 $3.0M +16.0% —
Aug 20SEC Aaron E. AltCFO Sell 12,22847,152 held (−21%) $235.54 $2.9M +16.8% —
Aug 20SEC Jessica L. MayerGeneral Counsel Sell 10,86433,076 held (−25%) $237.31 $2.6M +16.0% —
Aug 20SEC Stephen M. MasonCEO Sell 10,87630,890 held (−26%) $236.50 $2.6M +16.4% —
Aug 20SEC Jessica L. MayerGeneral Counsel Sell 10,24648,366 held (−17%) $235.51 $2.4M +16.9% —
Aug 20SEC Stephen M. MasonCEO Sell 8,19541,766 held (−16%) $235.62 $1.9M +16.8% —
Aug 20SEC Jason M. HollarCEO Sell 6,731213,034 held (−3%) $236.46 $1.6M +16.4% —
Aug 20SEC Deborah WeitzmanCEO Sell 6,66578,590 held (−8%) $235.30 $1.6M +17.0% —
Aug 20SEC Jason M. HollarCEO Sell 6,244190,603 held (−3%) $237.88 $1.5M +15.7% —
Aug 20SEC Jason M. HollarCEO Sell 6,206228,926 held (−3%) $233.22 $1.4M +18.0% —
Aug 20SEC Jason M. HollarCEO Sell 5,704219,765 held (−3%) $235.34 $1.3M +16.9% —
Aug 20SEC Michelle D. GreeneChief Information Officer Sell 4,95214,528 held (−25%) $235.68 $1.2M +16.8% —
Aug 20SEC Jessica L. MayerGeneral Counsel Sell 4,42643,940 held (−9%) $236.38 $1.0M +16.4% —
Aug 20SEC Jessica L. MayerGeneral Counsel Sell 3,90058,612 held (−6%) $234.64 $915K +17.3% —
Aug 20SEC Michelle D. GreeneChief Information Officer Sell 3,51211,016 held (−24%) $236.31 $830K +16.5% —
Aug 20SEC Jason M. HollarCEO Sell 3,457225,469 held (−2%) $234.29 $810K +17.5% —
Aug 20SEC Aaron E. AltCFO Sell 3,11559,380 held (−5%) $234.55 $731K +17.3% —
Aug 20SEC Stephen M. MasonCEO Sell 3,10049,961 held (−6%) $234.59 $727K +17.3% —
Aug 20SEC Michelle D. GreeneChief Information Officer Sell 2,50019,480 held (−11%) $234.57 $586K +17.3% —
Aug 20SEC Mary C. SchererChief Accounting Officer Sell 2,2022,811 held (−44%) $237.39 $523K +15.9% —
Aug 20SEC Michelle D. GreeneChief Information Officer Sell 68610,330 held (−6%) $237.25 $163K +16.0% —
Aug 20SEC Deborah WeitzmanCEO Sell 40878,182 held (−1%) $236.59 $97K +16.3% —
Aug 20SEC Deborah WeitzmanCEO Sell 28177,901 held (−0%) $237.44 $67K +15.9% —
Aug 20SEC Mary C. SchererChief Accounting Officer Sell 1005,013 held (−2%) $237.40 $24K +15.9% —
Mar 3SEC Michelle D. GreeneChief Information Officer Sell 2,64612,230 held (−18%) $228.47 $605K +20.5% —
Mar 3SEC Michelle D. GreeneChief Information Officer Sell 10014,876 held (−1%) $228.55 $23K +20.4% —
Feb 18SEC Aaron E. AltCFO Sell 2,32826,408 held (−8%) $225.50 $525K +22.0% —
Feb 10SEC Patricia Hemingway HallDirector Sell 4,00028,264 held (−12%) $229.72 $919K +19.8% —
Historical context

Similar past setups: not applicable. CAH has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with CAH in the Research Lab

CAH has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

CAH closeInsider buyInsider sale
150200250300DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-05EEarnings release filed 2026-04-30EEarnings release filed 2026-08-11EEarnings release filed 2026-11-05Sold $524,964 on 2026-02-18 · Aaron E. AltSold $627,387 on 2026-02-27 · Michelle D. GreeneSold $918,880 on 2026-02-06 · Patricia Hemingway HallSold $11,063,133 on 2026-08-19 · Jason M. Hollar, Mary C. SchererSold $48,489,309 on 2026-08-18 · Aaron E. Alt, Deborah Weitzman, Jason M. Hollar, Jessica L. Mayer, Michelle D. Greene, Stephen M. Mason
Bought, 12 months$0
Sold, 12 months$61.6M
Insiders buying0
Insiders selling8

Cardinal Health insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 8 sold $61.6M of CAH stock on the open market; P/E 35.6 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

CAH insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $2.1M sold (4 trades)Q1 2026Q2 2026Q3 2026: $59.6M sold (31 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$59.6M31
Q2 2026—0—0
Q1 2026—0$2.1M4

Valuation, profit and volume

P/E (trailing)35.6Sector median 25.0
Volume vs. 50-day0.8×Last 5 sessions

Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 Cardinal Health insiders reported open-market purchases totaling $0, while 8 insiders reported sales totaling $61.6M. 0 of 35 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

CAH earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Nov 5, 2026 +1.7% None +3.7%S&P -4.1% pending
Aug 11, 2026 +4.0% None -1.3%S&P -0.1% +0.2%
Apr 30, 2026 -5.6% None -3.7%S&P +1.3% +0.8%
Feb 5, 2026 -1.7% None +9.4%S&P +0.6% -3.8%
Oct 30, 2025 +6.7% None +16.0%S&P -0.8% +11.3%
Aug 12, 2025 +0.3% None -6.1%S&P +1.4% +2.8%
May 1, 2025 +5.2% None +5.8%S&P +2.2% +3.3%
Jan 30, 2025 +3.0% None -3.2%S&P +0.0% +4.7%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

CAH short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

Rising
20%40%60%2026-08-26: 58% of volume sold short2026-08-27: 53% of volume sold short2026-08-28: 42% of volume sold short2026-08-31: 61% of volume sold short2026-09-01: 56% of volume sold short2026-09-02: 50% of volume sold short2026-09-03: 59% of volume sold short2026-09-04: 44% of volume sold short2026-09-08: 36% of volume sold short2026-09-09: 51% of volume sold short2026-09-10: 44% of volume sold short2026-09-11: 47% of volume sold short2026-09-14: 42% of volume sold short2026-09-15: 48% of volume sold short2026-09-16: 58% of volume sold short2026-09-17: 49% of volume sold short2026-09-18: 53% of volume sold short2026-09-21: 40% of volume sold short2026-09-22: 36% of volume sold short2026-09-23: 47% of volume sold short2026-09-24: 51% of volume sold short2026-09-25: 39% of volume sold short2026-09-28: 46% of volume sold short2026-09-29: 58% of volume sold short2026-09-30: 61% of volume sold short2026-10-01: 51% of volume sold short2026-10-02: 63% of volume sold short2026-10-05: 47% of volume sold short2026-10-06: 54% of volume sold short2026-10-07: 58% of volume sold short2026-10-08: 55% of volume sold short2026-10-09: 46% of volume sold short2026-10-12: 62% of volume sold short2026-10-13: 37% of volume sold short2026-10-14: 53% of volume sold short2026-10-15: 48% of volume sold short2026-10-16: 58% of volume sold short2026-10-19: 53% of volume sold short2026-10-20: 64% of volume sold short2026-10-21: 63% of volume sold short2026-10-22: 63% of volume sold short2026-10-23: 68% of volume sold short2026-10-26: 74% of volume sold short2026-10-27: 74% of volume sold short2026-10-28: 68% of volume sold short2026-10-29: 58% of volume sold short2026-10-30: 82% of volume sold short2026-11-02: 74% of volume sold short2026-11-03: 71% of volume sold short2026-11-04: 64% of volume sold short2026-11-05: 58% of volume sold short2026-11-06: 56% of volume sold short2026-11-09: 71% of volume sold short2026-11-10: 65% of volume sold short2026-11-11: 50% of volume sold short2026-11-12: 62% of volume sold short2026-11-13: 63% of volume sold short2026-11-16: 68% of volume sold short2026-11-17: 52% of volume sold short2026-11-18: 63% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 63%20-day average: 65%Prior 2 months: 51%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded CAH

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 +34.1%

Insiders at Cardinal Health

InsiderBoughtSoldLast filingPast buys beat S&PScore
Jason M. HollarCEO — $29.4M Aug 20, 2026 — —
Aaron E. AltCFO — $10.5M Aug 20, 2026 — —
Stephen M. MasonCEO — $8.3M Aug 20, 2026 — —
Jessica L. MayerGeneral Counsel — $7.0M Aug 20, 2026 — —
Michelle D. GreeneChief Information Officer — $3.4M Aug 20, 2026 — —
Deborah WeitzmanCEO — $1.7M Aug 20, 2026 — —
Patricia Hemingway HallDirector — $919K Nov 16, 2026 — —
Mary C. SchererChief Accounting Officer — $546K Aug 20, 2026 — —
Robert AzelbyDirector — — Nov 16, 2026 — —
Christine MundkurDirector — — Nov 16, 2026 — —
David C. EvansDirector — — Nov 16, 2026 — —
Robert W. MusslewhiteDirector — — Nov 16, 2026 — —
Sheri H. EdisonDirector — — Nov 16, 2026 — —
Sudhakar RamakrishnaDirector — — Nov 16, 2026 — —
Akhil JohriDirector — — Nov 16, 2026 — —
Nancy KilleferDirector — — Nov 16, 2026 — —
Michelle BrennanDirector — — Nov 16, 2026 1 of 1 —
Valerie Christine PitteroffChief Human Resources Officer — — Aug 18, 2026 — —
Ola M. SnowChief Human Resources Officer — — Dec 2, 2025 1 of 1 —
Gregory B. KennyDirector — — Nov 6, 2025 — —

Board links: companies that share insiders with CAH

Directors and executives who filed Form 4s for CAH and another company in the last 12 months.

See the map →
  • BABoeing Akhil Johri Director here · Director at BA · latest filing Nov 18, 2026
  • CSGPCoStar Group Robert W. Musslewhite Director here · Director at CSGP · latest filing Nov 16, 2026
  • DVADaVita Jason M. Hollar CEO here · Director at DVA · latest filing Nov 17, 2026
  • KDPKeurig Dr Pepper Aaron E. Alt CFO here · Director at KDP · latest filing Aug 27, 2026
  • METAMeta Platforms Nancy Killefer Director here · Director at META · latest filing Nov 16, 2026
  • SMGScotts Miracle-gro David C. Evans Director here · Director at SMG · latest filing Nov 16, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

CAH stock: common questions

Are Cardinal Health insiders buying CAH stock?

No. No Cardinal Health insider reported an open-market purchase of CAH in the past 12 months.

Are Cardinal Health insiders selling CAH stock?

8 insiders reported sales worth $61.6M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is CAH's P/E ratio?

CAH trades at about 35.6 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is CAH's 52-week range?

Over the past year CAH has traded between $181.68 and $283.85. It last closed at $275.21 on Nov 20, 2026.